trending Market Intelligence /marketintelligence/en/news-insights/trending/p7yw5oupyucrcymurmexxq2 content esgSubNav
In This List

Novan names board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Novan names board member

Morrisville, N.C.-based biotechnology company Novan Inc. appointed Eugene Sun to the board, effective Feb. 16.

Sun was CEO of Melinta Therapeutics from 2015 to 2017. He also served on the now-defunct U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee, a panel of infectious disease experts, from 2001 to 2007.